Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.

Annals of hematology - 1 Aug 2014

Brito Angelo Borsarelli Carvalho, Lourenço Gustavo Jacob, Oliveira Gislaine Borba, De Souza Cármino Antônio, Vassallo José, Lima Carmen Silvia Passos

Abstract excerpt

Angiogenesis has been highlighted as a critical component in the progression of multiple myeloma (MM), and vascular endothelial growth factor (VEGF) as well as its type 2 receptor (VEGFR2) are thought to play a major role in the process. Single nucleotide polymorphisms (SNPs) have been described in VEGF and VEGFR2 genes, with quantitative or qualitative changes in encoded VEGF and VEGFR2. The roles of VEGF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5' Untranslated Regions
Share to Multiple Myeloma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplasm Proteins

Share to Neoplasm Staging

Share to Neovascularization, Pathologic

Share to Vascular Endothelial Growth Factor A

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 24687381
DOI: 10.1007/s00277-014-2062-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.PMID 24687381Read ↗

Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.Semantic proximity Read ↗

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.Semantic proximity Read ↗

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.Semantic proximity Read ↗

Association between tumor necrosis factor alpha gene polymorphisms and multiple myeloma risk: an updated meta-analysis.Semantic proximity Read ↗

The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma.Semantic proximity Read ↗

Association of VEGF and VDR gene- gene and gene- smoking interaction on risk of multiple myeloma in Chinese Han population.Semantic proximity Read ↗

Effects of TNFα, NOS3, MDR1 Gene Polymorphisms on Clinical Parameters, Prognosis and Survival of Multiple Myeloma Cases.Semantic proximity Read ↗

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.Semantic proximity Read ↗

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.Semantic proximity Read ↗

Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.Semantic proximity Read ↗

Construction and validation of a prognostic model of angiogenesis-related genes in multiple myelomaSemantic proximity Read ↗

The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.